Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective …

DJ Angiolillo, DL Bhatt, CP Cannon, JW Eikelboom… - Circulation, 2021 - Am Heart Assoc
A growing number of patients undergoing percutaneous coronary intervention (PCI) with
stent implantation also have atrial fibrillation. This poses challenges for their optimal …

Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey

D Cao, R Chandiramani, M Chiarito… - European Heart …, 2021 - academic.oup.com
Since its introduction in 1977, percutaneous coronary intervention has become one of the
most commonly performed therapeutic procedures worldwide. Such widespread diffusion …

Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research

VARC-3 Writing Committee, P Généreux… - European heart …, 2021 - academic.oup.com
Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials

MV Madhavan, JP Howard, A Naqvi… - European Heart …, 2021 - academic.oup.com
Aims Contemporary 2nd-generation thin-strut drug-eluting stents (DES) are considered
standard of care for revascularization of patients undergoing percutaneous coronary …

Soluble platelet release factors as biomarkers for cardiovascular disease

G Baidildinova, M Nagy, K Jurk, PS Wild… - Frontiers in …, 2021 - frontiersin.org
Platelets are the main players in thrombotic diseases, where activated platelets not only
mediate thrombus formation but also are involved in multiple interactions with vascular cells …

Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the …

DA Gorog, S Price, D Sibbing… - European Heart …, 2021 - academic.oup.com
abstract Timely and effective antithrombotic therapy is critical to improving outcome,
including survival, in patients with acute coronary syndrome (ACS). Achieving effective …

[HTML][HTML] Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the Russian Association of Gerontologists and Geriatricians and the …

ON Tkacheva, NM Vorobyeva… - Cardiovascular …, 2021 - cardiovascular.elpub.ru
Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the
Russian Association of Gerontologists and Geriatricians and the National Society of Preventive …

Transradial versus transfemoral access for percutaneous coronary intervention in ST-segment–elevation myocardial infarction: a systematic review and meta-analysis

P Di Santo, T Simard, GA Wells, RG Jung… - Circulation …, 2021 - Am Heart Assoc
Background: Transradial access (TRA) has emerged as the preferred vascular access site
for coronary angiography and percutaneous coronary intervention. This systematic review …

Ticagrelor monotherapy versus dual-antiplatelet therapy after PCI: an individual patient-level meta-analysis

M Valgimigli, R Mehran, A Franzone… - Cardiovascular …, 2021 - jacc.org
Objectives The aim of this study was to compare ticagrelor monotherapy with dual-
antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting …

Extracorporeal membrane oxygenation complications in heparin-and bivalirudin-treated patients

K Giuliano, BF Bigelow, EW Etchill… - Critical care …, 2021 - journals.lww.com
OBJECTIVES: Extracorporeal membrane oxygenation is a potentially life-saving intervention
in refractory cardiopulmonary failure, but it requires anticoagulation to prevent circuit …